.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cantor Fitzgerald
Covington
Moodys
Healthtrust
AstraZeneca
Cerilliant
Deloitte
Baxter
QuintilesIMS

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020647

« Back to Dashboard

NDA 020647 describes ELDEPRYL, which is a drug marketed by Somerset and is included in one NDA. It is available from one supplier. Additional details are available on the ELDEPRYL profile page.

The generic ingredient in ELDEPRYL is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.

Summary for 020647

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020647

Suppliers and Packaging for NDA: 020647

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ELDEPRYL selegiline hydrochloride CAPSULE;ORAL 020647 NDA Mylan Specialty L.P. 49502-420 49502-420-60 60 CAPSULE in 1 BOTTLE (49502-420-60)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength5MG
Approval Date:May 15, 1996TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Dow
US Department of Justice
Chubb
Mallinckrodt
Baxter
Fuji
Medtronic
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot